• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

工程抗体治疗传染病。

Engineering Antibodies for the Treatment of Infectious Diseases.

机构信息

Department of Clinical Laboratory, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.

National Center for Clinical Laboratories, Beijing Hospital, National Center of Gerontology, Beijing, China.

出版信息

Adv Exp Med Biol. 2017;1053:207-220. doi: 10.1007/978-3-319-72077-7_10.

DOI:10.1007/978-3-319-72077-7_10
PMID:29549641
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7121079/
Abstract

Historically, serum therapy was previously used to combat infectious pathogens. However, serum sickness and anaphylaxis limited its broad application. The advancement of antibody engineering technologies has made it feasible to generate monoclonal antibodies. There are divergent methods for antibody engineering and optimization. In this chapter, we summarized the latest developments in engineering antibodies for infectious diseases.

摘要

从历史上看,血清疗法曾被用于对抗感染性病原体。然而,血清病和过敏反应限制了其广泛应用。抗体工程技术的进步使得生成单克隆抗体成为可能。抗体工程和优化有不同的方法。在本章中,我们总结了用于传染病的抗体工程的最新进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a5/7121079/616258216132/418104_1_En_10_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a5/7121079/ebdb5c769781/418104_1_En_10_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a5/7121079/616258216132/418104_1_En_10_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a5/7121079/ebdb5c769781/418104_1_En_10_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c7a5/7121079/616258216132/418104_1_En_10_Fig2_HTML.jpg

相似文献

1
Engineering Antibodies for the Treatment of Infectious Diseases.工程抗体治疗传染病。
Adv Exp Med Biol. 2017;1053:207-220. doi: 10.1007/978-3-319-72077-7_10.
2
Immune Human Antibody Libraries for Infectious Diseases.免疫人抗体文库用于传染病。
Adv Exp Med Biol. 2017;1053:61-78. doi: 10.1007/978-3-319-72077-7_4.
3
Naïve Human Antibody Libraries for Infectious Diseases.用于传染病的原始人类抗体文库。
Adv Exp Med Biol. 2017;1053:35-59. doi: 10.1007/978-3-319-72077-7_3.
4
Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology.传染病中的抗体:多克隆抗体、单克隆抗体和利基生物技术。
N Biotechnol. 2011 Sep;28(5):489-501. doi: 10.1016/j.nbt.2011.03.018. Epub 2011 Apr 5.
5
Safety and General Considerations for the Use of Antibodies in Infectious Diseases.抗体在传染病中的应用的安全性和一般注意事项。
Adv Exp Med Biol. 2017;1053:265-294. doi: 10.1007/978-3-319-72077-7_13.
6
Synthetic Antibodies in Infectious Disease.传染病中的合成抗体
Adv Exp Med Biol. 2017;1053:79-98. doi: 10.1007/978-3-319-72077-7_5.
7
The use of antibodies in the treatment of infectious diseases.抗体在传染病治疗中的应用。
Singapore Med J. 2009 Jul;50(7):663-72; quiz 673.
8
Monoclonal Antibodies and Antibody Like Fragments Derived from Immunised Phage Display Libraries.免疫噬菌体展示文库衍生的单克隆抗体和抗体样片段。
Adv Exp Med Biol. 2017;1053:99-117. doi: 10.1007/978-3-319-72077-7_6.
9
The biotechnology and applications of antibody engineering.抗体工程的生物技术及其应用
Mol Biotechnol. 1995 Apr;3(2):139-54. doi: 10.1007/BF02789110.
10
Engineering at the limits of antibody space.在抗体空间极限下的工程学。
Protein Eng Des Sel. 2013 Oct;26(10):559-60. doi: 10.1093/protein/gzt051.

引用本文的文献

1
Preparation of Monoclonal Antibodies Against the gD Protein of Feline Herpesvirus Type-1 by mRNA Immunization.通过mRNA免疫制备抗猫疱疹病毒1型gD蛋白的单克隆抗体
Vet Sci. 2025 Jun 20;12(7):601. doi: 10.3390/vetsci12070601.
2
Purification of Monoclonal Antibodies Using Chromatographic Methods: Increasing Purity and Recovery.使用色谱方法纯化单克隆抗体:提高纯度和回收率
Adv Pharm Bull. 2025 Jan 5;15(1):27-45. doi: 10.34172/apb.43967. eCollection 2025 Apr.
3
Polyclonal Antibodies Derived from Transchromosomic Bovines Vaccinated with the Recombinant F1-V Vaccine Increase Bacterial Opsonization In Vitro and Protect Mice from Pneumonic Plague.

本文引用的文献

1
Bispecific antibodies and their applications.双特异性抗体及其应用。
J Hematol Oncol. 2015 Dec 21;8:130. doi: 10.1186/s13045-015-0227-0.
2
Analysis and purification of IgG4 bispecific antibodies by a mixed-mode chromatography.通过混合模式色谱法分析和纯化IgG4双特异性抗体。
Anal Biochem. 2015 Sep 1;484:173-9. doi: 10.1016/j.ab.2015.06.014. Epub 2015 Jun 16.
3
Evaluating large-scale blood transfusion therapy for the current Ebola epidemic in Liberia.评估针对利比里亚当前埃博拉疫情的大规模输血治疗。
用重组F1-V疫苗接种的转染色体牛产生的多克隆抗体可增强体外细菌调理作用,并保护小鼠免受肺鼠疫感染。
Antibodies (Basel). 2023 May 8;12(2):33. doi: 10.3390/antib12020033.
4
Development of broadly neutralizing antibodies targeting the cytomegalovirus subdominant antigen gH.开发针对巨细胞病毒亚显性抗原 gH 的广谱中和抗体。
Commun Biol. 2022 Apr 25;5(1):387. doi: 10.1038/s42003-022-03294-z.
J Infect Dis. 2015 Apr 15;211(8):1262-7. doi: 10.1093/infdis/jiv042. Epub 2015 Jan 29.
4
Infectious diseases: Two-hit antibody tackles bacteria.传染病:双效抗体对抗细菌。
Nat Rev Drug Discov. 2015 Jan;14(1):15. doi: 10.1038/nrd4525.
5
High-throughput sequencing analysis of post-liver transplantation HCV E2 glycoprotein evolution in the presence and absence of neutralizing monoclonal antibody.肝移植后丙型肝炎病毒E2糖蛋白在存在和不存在中和性单克隆抗体情况下进化的高通量测序分析
PLoS One. 2014 Jun 23;9(6):e100325. doi: 10.1371/journal.pone.0100325. eCollection 2014.
6
A novel anti-PcrV antibody providing enhanced protection against Pseudomonas aeruginosa in multiple animal infection models.一种新型抗PcrV抗体,在多种动物感染模型中对铜绿假单胞菌提供增强的保护作用。
Antimicrob Agents Chemother. 2014 Aug;58(8):4384-91. doi: 10.1128/AAC.02643-14. Epub 2014 May 19.
7
Assessment of naturally occurring covalent and total dimer levels in human IgG1 and IgG2.评估人 IgG1 和 IgG2 中的天然形成的共价和总二聚体水平。
Mol Immunol. 2014 Mar;58(1):108-15. doi: 10.1016/j.molimm.2013.11.011. Epub 2013 Dec 8.
8
Molecular deconvolution of the monoclonal antibodies that comprise the polyclonal serum response.对构成多克隆血清反应的单克隆抗体进行分子剖析。
Proc Natl Acad Sci U S A. 2013 Feb 19;110(8):2993-8. doi: 10.1073/pnas.1213737110. Epub 2013 Feb 4.
9
Human monoclonal antibody MBL-HCV1 delays HCV viral rebound following liver transplantation: a randomized controlled study.人源化单克隆抗体 MBL-HCV1 延迟肝移植后 HCV 病毒复发:一项随机对照研究。
Am J Transplant. 2013 Apr;13(4):1047-1054. doi: 10.1111/ajt.12083. Epub 2013 Jan 28.
10
High-throughput sequencing of the paired human immunoglobulin heavy and light chain repertoire.高通量测序人类免疫球蛋白重链和轻链配对库。
Nat Biotechnol. 2013 Feb;31(2):166-9. doi: 10.1038/nbt.2492. Epub 2013 Jan 20.